StockGlow

Nexalin Technology, Inc. (NXL)

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China.

$0.35+0.02%Healthcare
Compare NXL with
StockGlow Score
20
Leaning Bearish
BearishBullish
1 year ago-64.6%

The outlook

Nexalin Technology, Inc. currently reads as leaning bearish based on below its 50- & 200-day averages, 3% of the way from its 52-week low to high, avg target +472% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +472% vs current price
Market cap
$7.7M
52-wk high
$2.00
52-wk low
$0.31
50-day avg
$0.43
200-day avg
$0.64
Trailing P/E
—

Similar stocks

CRECre8 Enterprise Limited$2.46-5.02%NHPNational Healthcare Properties, Inc.$15.23-0.85%BIVIBioVie Inc.$1.47+2.80%CLDICalidi Biotherapeutics, Inc.$1.69+13.21%AIMDAinos, Inc.$1.35-0.74%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy